Cargando…
New developments in the treatment of osteoarthritis – focus on biologic agents
Osteoarthritis (OA) is one of the most common diseases around the world. Medical, social, and financial consequences oblige clinicians, surgeons, and researchers to focus on finding the best treatment option, to eradicate and stop this degenerative joint disease, in order to avoid surgical options w...
Autores principales: | Torrero, Jose Ignacio, Martínez, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045124/ https://www.ncbi.nlm.nih.gov/pubmed/27790043 http://dx.doi.org/10.2147/OARRR.S50058 |
Ejemplares similares
-
Nutraceutical Activity in Osteoarthritis Biology: A Focus on the Nutrigenomic Role
por: D’Adamo, Stefania, et al.
Publicado: (2020) -
New developments in osteoarthritis. Posttraumatic osteoarthritis: pathogenesis and pharmacological treatment options
por: Lotz, Martin K
Publicado: (2010) -
Overview of First-Line and Second-Line Pharmacotherapies for Osteoarthritis with Special Focus on Intra-Articular Treatment
por: Nowaczyk, Alicja, et al.
Publicado: (2022) -
New class of agents for treatment of hypertension: focus on direct renin inhibition
por: Fogari, Roberto, et al.
Publicado: (2010) -
A Roadmap of In Vitro Models in Osteoarthritis: A Focus on Their Biological Relevance in Regenerative Medicine
por: Bartolotti, Isabella, et al.
Publicado: (2021)